5/15/2013

Guidelines for opioid drug conversion vary and sometimes conflict, and are based on single-dose studies that lack long-term data, according to a Purdue Pharma study presented at a meeting of the American Pain Society. The biggest variation was found in recommendations for hydromorphone and oxycodone. Dr. John Peppin of the Palliative Care Center in Lexington, Ky., agreed there is a problem, and physicians are aware of it.

Related Summaries